✦ LIBER ✦

Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load

✍ Scribed by Karin Neukam; Angela Camacho; Antonio Caruz; Norma Rallón; Almudena Torres-Cornejo; Jürgen K. Rockstroh; Juan Macías; Antonio Rivero; José M. Benito; Luis F. López-Cortés; Jacob Nattermann; Jesús Gómez-Mateos; Vicente Soriano; Juan A. Pineda

Book ID: 116652663
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 864 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2011.11.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

F-45 Rapid virologic response (RVR), IL2

F-45 Rapid virologic response (RVR), IL28B single nucleotide polymorphism (SNP) rs12980275 and HCV genotype are independent predictors of sustained virologic response (SVR) in HIV/HCV coinfected patients treated with pegylated interferon and ribavirin

✍ M. Puoti; L. Covolo; P. Nasta; F. Gatti; F. Suter; C. Mussini; R. Bruno; C. Ferr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Plasma HCV-RNA decline in the first 48 h

Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy

✍ J. E. Arends; J. Cohen Stuart; L. C. Baak; M. E. Van Der Ende; K. J. Van Erpecum 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB

Predicting the response to 48-week combi

Predicting the response to 48-week combination therapy with peginterferon α-2b plus ribavirin from the estimated HCV RNA load index after negative serum change in genotype 1b hepatitis C patients

✍ Keiji Tsuji; Yoshiiku Kawakami; Shiomi Aimitsu; Hiroshi Kohno; Yasuyuki Aisaka; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

Usefulness of simple assays for serum co

Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon α2a therapy

✍ Toshio Suzuki; Eiji Tanaka; Akihiro Matsumoto; Akihiko Urushihara; Takeshi Sodey 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 781 KB

## Abstract The use of two new assays was evaluated for predicting the response to interferon (IFN) therapy in patients with chronic hepatitis C. The genotype of hepatitis C virus (HCV) was establishe by an enzyme‐linked immunosorbent assay based on genotype‐specific recombinant peptides of the NS4

271 EXTENDED TREATMENT OF TREATMENT-NAIV

271 EXTENDED TREATMENT OF TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) GENOTYPE 1-INFECTION AND SLOW RESPONSE TO PEGYLATED INTERFERON-ALFA AND RIBAVIRIN: A META-ANALYSIS

✍ C.M. Lange; H. Farnik; C. Sarrazin; B. Kronenberger; S. Zeuzem; E. Herrmann 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

IL28B But Not ITPA Polymorphism Is Predi

IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C

✍ Kamatani, N.; Sezaki, H.; Chayama, K.; Hayes, C. N.; Abe, H.; Miki, D.; Ochi, H. 📂 Article 📅 2011 🏛 University of Chicago Press 🌐 English ⚖ 454 KB